Poseida Therapeutics, Inc. (PSTX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-05-22	Dec-31-21	Dec-05-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17
	10-K	8-K	10-K	8-K	10-K	10-K	S-1/A	S-1/A
Net income	-64.0	-64.0	-125.0	-125.0	-129.8	-86.5	-44.4	0.0
Depreciation and amortization	5.2		4.6		2.6	1.2	0.7	0.7
Stock-based compensation					7.2	3.1	1.0	0.4
Deferred taxes							-0.2	-0.5
Change in working capital [+]	47.5		64.4		45.9	37.0	1.7	-0.8
Accounts receivable								0.9
Other current assets					-3.3	0.7
Accounts payable					-4.2	1.5	1.0	0.0
Accrued expenses					10.3	7.1
Deferred revenues	27.3		13.8
Other	20.3		50.7		43.1	27.7	0.7	-1.7
Other operating activities	-15.5		-46.6		-39.2	-19.3	3.3	-22.4
Cash from operations	-26.8		-102.5		-113.3	-64.5	-38.0	-22.7

Capital expenditures [+]	3.9		2.6		-16.9	-5.2	-1.3	-0.2
Purchases of property and equipment	3.9		2.6		-16.9	-5.2	-1.3	-0.2
Sales of property and equipment	0.0		0.0
Purchases of short-term investments, net	294.4				-187.5	-37.3
Purchases of short-term investments	294.4				-295.0	-71.3
Sales of short-term investments					107.5	34.0
Other cash from investing	-501.7		219.7
Cash from investing	-203.3		222.4		-204.4	-42.5	-1.3	-0.2

Issuance of common stock, net	75.3				205.7
Option exercises	1.5		4.5		0.2	0.1
Financing costs	1.5				-0.3	-0.1
Other cash from financing	32.8		7.0		108.1	164.4	54.1	20.6
Cash from financing	105.2		2.5		313.9	164.4	54.1	20.6

Free cash flow	-22.8		-99.9		-130.2	-69.7	-39.3	-22.9
Per share (diluted)	($0.32)		($1.61)		($3.62)	($5.52)	($3.23)

Cash paid for interest	5.1		2.7		3.0	2.6